You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
Follow
Students
Alumni
Faculty
Media
Careers
Libraries
microbio-parasites-arthropods
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
COVID Updates
Admissions, Pakistan
Admissions, East Africa
News
Events
WearAKU
University Hospitals
Examination Board
About Us
About AKU
AKU at a Glance
Our Vision & Mission
Founder & Chancellor
Board of Trustees
Office of the President
Deans & Officers
University Charters
Environment & Sustainability
Our Partners
Aga Khan Development Network
Academics
Pakistan
Uganda
Kenya
Tanzania
United Kingdom
Admissions
Undergraduate Programmes
Graduate Programmes
Doctoral Programmes
Key Admissions Dates
Fees and Funding
Registrar’s Office
Research
About Us
University Research Council
Grants & Funding Opportunities
Ethics Review Board & Committees
Core Facilities
Clinical Research Unit, Kenya
Clinical Trials Unit, Pakistan
Global Institutes & Centres
Arusha Climate & Environmental Research Centre
Brain & Mind Institute
Centre for Innovation in Medical Education
Centre of Excellence in Women & Child Health
Institute for Global Health & Development
Institute for Human Development
Support Us
Give Now
Giving Opportunities
Ways to Give
Impact of Giving
Recognising our Donors
Information for
Students
Alumni
Faculty
Media
Careers
Libraries
onwards
March 1983-2023
SEE OUR JOURNEY
Home
Research
Groups & Partners
Groups & Partners
Currently selected
Microbiology
Vector-borne and Malarial Diseases Research Group
FOCUS
In vitro and molecular resistance patterns antimalarial drugs
Diagnosis, epidemiology, molecular analysis, pathogenesis and emerging drug resistance of vecto
Molecular epidemiology of Plasmodium species,
r-borne infections
RESEARCHERS
Dr M Asim Beg
Dr Erum Khan
Dr Najia Ghanchi
Dr Afsheen Raza
Dr Joveria Farooqi
Dr Sadia Shakoor
Ms Amna Nasir
Dr Akbar Kanji
Ms Muniba Islam
Dr Ali Bin Sarwar Zubairi
COLLABORATORS/PARTNERS
London School of Hygiene and Tropical Medicine, UK.
Malaria Control Program, Pakistan.
Harvard school of Public Health, USA
Malaria Branch, Centres for Disease Control (CDC), USA
CURRENT PROJECTS
The Role of Arboviruses undifferentiated as a cause of febrile illness in Sindh Pakistan
Funded by DTRA. $ 116,796. 2014-2017.
Identification for severity markers in vivax malaria
Rs 1,630,055. 2011-2014.
Antimalarial resistance in P. falciparum: Role of single nucleotide polymorphism in resistance associated genes and in vitro drug sensitivities.
USD $15,000. 2012 - 2014
PREVIOUSLY FUNDED PROJECTS
Point-of-Care Technology for the Diagnosis of Multiple Diseases: A Solution to the Disease Overtreatment Problem.
100,000 CAD. Funded by Canadian Grand Challenges. 2012.
Dr Michael Serpe (University of Alberta)
Molecular basis of glucose-6-phoshate dehydrogenase deficiency in the Afghan population
$10,000. Funded by Health Net, London School of Hygiene and Tropical Medicine. 2011.
Emerging infectious agents mimicking functional bowel disease.
Rs. 1 million Funded by the Government of Pakistan Higher Education Commission. 2008- 2010.
P.vivax malaria: Population genetics and markers of drug resistance in an endemic region.
WHO $ 9,000. 2008-2009.
Genetic Diversity of Plasmodium Falciparum Candidate Antigen Genes among Field Isolates from Karachi, Pakistan.
$ 31,700. 2005-2009.
Relationship of disease severity to serum cytokine profiles, serological and virological data in patients with dengue fever and dengue hemorrhagic fever.
Funded by URC. Mar 08-Feb 2010.
Molecular characterization of molecular drug resistance markers in P. falciparum isolates from Karachi.
SEK 60,000 Funded by SASNET, Sweden and the Malaria Research Unit of Karolinska Institutet, Sweden. 2006.
Development of a simple bedside applicable tool for diagnosis of severe malaria
$8,500. 2003-2006.
Establishment of in vitro test to detect chloroquine resistance P. falciparum among patients attending AKUH. In vivo drug resistance in P. falciparummalaria.
US $10,000.1999 – 2001.
CONTACT
Dr M Asim Beg
Dr Erum Khan